It is also well known that FUS can enter the nucleus and that mutation are associated with its cytoplasmic localization, which is associated with a variety of neurodegenerative diseases and suggests that cytoplasmic FUS might be a reliable indicator of glioma malignancy. This evidence concerns the gene FUS and glioma.